Psychiatric comorbidity in a cohort of heroin and amphetamine users in Perth, Western Australia

References

• Cantwell R, Brewin J, Glazebrook C, Dalkin T, Fox R, Medley I and Harrison G (1999) Prevalence of substance misuse in first-episode psychosis. British Journal of Psychiatry 174: 150–3.
   PubMed Web of Science ®Google Scholar
• Daniels BA, Kirkby KC, Hay DA, Mowry BJ and Jones IH (1998) Predictability of rehospitalisation over 5 years for schizophrenia, bipolar disorder and depression. Australian and New Zealand Journal of Psychiatry 32 (2): 281–6.
   PubMed Web of Science ®Google Scholar
• Darke S, Swift W and Hall W (1994) Prevalence, severity and correlates of psychological morbidity among methadone main-tenance clients. Addiction 89 (2): 211–17.
   PubMed Web of Science ®Google Scholar
• Drake RE and Wallach MA (1989) Substance abuse among the chronic mentally ill. Hospital and Community Psychiatry 40 (10): 1041–5.
   PubMedGoogle Scholar
• el-Guebaly N (1990) Substance abuse and mental disorders: the dual diagnosis concept. Canadian Journal of Psychiatry 35 (3): 261–7.
   Google Scholar
• Grant BF (1995) Comorbidity between DSM-IV drug use disorders and major depression: results of a national survey of adults. Journal of Substance Abuse 7 (4): 481–97.
   PubMedGoogle Scholar
• Hansten ML, Downey L, Rosengren DB and Donovan DM (2000) Relationship between follow-up rates and treatment outcomes in substance abuse research: more is better but when is 'enough' enough? Addiction 95 (9): 1403–16.
   Google Scholar
• Harrison CA and Abou-Saleh MT (2002) Psychiatric disorders and substance misuse: psychopathology. In: Rassool GH (ed.) Dual Diagnosis: Substance Misuse & Psychiatric Disorders. Blackwell Science: London, pp. 43-57.
   Google Scholar
• Holman CDJ, Bass AJ, Rouse IL and Hobbs MST (1999) Population-based linkage of health records in Western Australia: development of a health services research linked database. Australia and New Zealand Journal of Public Health 23 (5): 453–9.
   PubMed Web of Science ®Google Scholar
• Johnson ME, Brems C and Burke S (2002) Recognizing comorbidity among drug users in treatment. American Journal of Drug and Alcohol Abuse 28 (2): 243–61.
   PubMed Web of Science ®Google Scholar
• Khantzian EJ (1985) The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. American Journal of Psychiatry 142 (11): 1259–64.
   PubMed Web of Science ®Google Scholar
• Lehman AF, Myers CP and Corty E (1989) Assessment and classification of patients with psychiatric and substance abuse syndromes. Hospital and Community Psychiatry 40 (10): 1019–25.
   PubMedGoogle Scholar
• Limbeek JV, Wouters L, Kaplan CD, Geerlings PJ and Alem VV (1992) Prevalence of psychopathology in drug-addicted Dutch. Journal of Substance Abuse Treatment 9 (1): 43–52.
   Google Scholar
• Mason BJ, Kocsis JH, Melia D, Khuri ET, Sweeney J, Wells A, Borg L, Millman RB and Kreek Mj (1998) Psychiatric comorbidity in methadone maintained patients. Journal of Addictive Diseases 17 (3): 75–89.
   PubMed Web of Science ®Google Scholar
• Mueser KT, Bellack AS and Blanchard JJ (1992) Comorbidity of schizophrenia and substance abuse: implications for treatment. Journal of Consulting & Clinical Psychology 60 (6): 845–56.
   PubMed Web of Science ®Google Scholar
• Mueser KT, Yamold PR, Rosenberg SD, Swett Jr C, Miles KM and Hill D (2000) Substance use disorders in hospitalised severely mentally ill psychiatric patients: prevalence, correlates and sub-groups. Schizophrenia Bulletin 26 (1): 179–92.
   PubMed Web of Science ®Google Scholar
• Negrete JC, Knapp WP, Douglas DE and Smith WB (1986) Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey. Psychological Medicine 16 (3): 515–20.
   PubMed Web of Science ®Google Scholar
• Nemes S, Wish E, Wraight B and Messina N (2002) Correlates of treatment follow-up difficulty. Substance Use & Misuse 37 (1): 19–45.
   PubMed Web of Science ®Google Scholar
• Nigam R, Schottenfeld R and Kosten TR (1992) Treatment of dual diagnosis patients: a relapse prevention group approach. Journal of Substance Abuse Treatment 9 (9): 305–9.
   Google Scholar
• Richard ML, Liskow BI and Perry PJ (1985) Recent psychostimulant use in hospitalized schizophrenics. Journal of Clinical Psychiatry 46 (3): 79–83.
   PubMed Web of Science ®Google Scholar
• Roberts RO, Bergstralh EJ, Schmidt L and Jacobsen SJ (1996) Comparison of self-reported and medical record health care utilization measures. Journal of Clinical Epidemiology 49 (9): 989–95.
   PubMed Web of Science ®Google Scholar
• Rosenthal RN and Miner CR (1997) Differential diagnosis of substance-induced psychosis and schizophrenia in patients with substance use disorders. Schizophrenia Bulletin 23 (2): 187–93.
   PubMed Web of Science ®Google Scholar
• Ross HE, Glaser FB and Germanson T (1988) The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Archives of General Psychiatry 45 (1): 1023–31.
   Google Scholar
• Rounsaville BJ and Kleber HD (1985) Untreated opiate addicts: how do they differ from those seeking treatment? Archives of General Psychiatry 42 (11): 1072–7.
   Google Scholar
• Rounsaville BJ, Weissman MM, Crits-Christoph K, Wilber C and Kleber H (1982) Diagnosis and symptoms of depression in opiate addicts: course and relation to treatment outcome. Archives of General Psychiatry 39 (2): 151–6.
   PubMedGoogle Scholar
• Rounsaville BJ, Kosten TR, Weissman MW, Prusoff B, Pauls D, Anton SF and Merikangas K (1991) Psychiatric disorders in relatives of probands with opiate addiction. Archives of General Psychiatry 48 (1): 33–42.
   PubMedGoogle Scholar
• Sacks S (2000) Co-occurring mental and substance abuse disorders: promising approaches and research issues. Substance Use & Misuse 35 (12-14): 2061–93.
   PubMed Web of Science ®Google Scholar
• San L, Torrens M, Tato J, Castillo C, de la Tone R and Arranz B (1998) Monitoring patterns of substance use in drug dependent patients. Journal of Substance Abuse Treatment 15 (5): 425–30.
   Google Scholar
• Schneier FR and Sins SG (1987) A review of psychoactive substance use and abuse in schizophrenia: patterns of drug choice. Journal of Nervous Mental Disease 175 (11): 641–50.
   PubMed Web of Science ®Google Scholar
• Strain EC, Brooner RK and Bigelow GE (1991) Clustering of multiple substance use and psychiatric diagnoses in opiate addicts. Drug & Alcohol Dependence 27 (2): 127–34.
   Google Scholar
• Unwin E, Garfield C and Gawthorne G (2003) Record Linkage Methods Used in the Evaluation of Long-Term Health Outcomes for Illicit Drug Users. Epidemiology & Analytical Services, Department of Health: Perth, WA.
   Google Scholar
• Wallihan DB, Stump TE and Callahan CM (1999) Accuracy of self-reported health services use and patterns of care among urban older adults. Medical Care 37 (7): 662–70.
   Google Scholar
• White V (2001) Australian Secondary Students' Use of Over-the-Counter and Illicit Substances in 1999. Commonwealth Department of Health and Aged Care: Canberra, ACT.
   Google Scholar